MEREO BIOPHARMA GROUP PLC's ticker is MREO and the CUSIP is 589492107. A total of 57 filers reported holding MEREO BIOPHARMA GROUP PLC in Q3 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $191,281 | -36.3% | 591,676 | -33.6% | 0.02% | -52.1% |
| Q2 2023 | $300,235 | +50.9% | 891,676 | +44.8% | 0.05% | +33.3% |
| Q2 2022 | $199,000 | -37.4% | 615,856 | -32.8% | 0.04% | -14.3% |
| Q1 2022 | $318,000 | +3.6% | 915,856 | +7.3% | 0.04% | -8.7% |
| Q4 2021 | $307,000 | -4.7% | 853,680 | -5.5% | 0.05% | +100.0% |
| Q3 2021 | $322,000 | -6.9% | 903,680 | -4.3% | 0.02% | -17.9% |
| Q2 2021 | $346,000 | -17.4% | 944,308 | -17.6% | 0.03% | +100.0% |
| Q1 2021 | $419,000 | +0.7% | 1,146,308 | 0.0% | 0.01% | -22.2% |
| Q4 2020 | $416,000 | -39.5% | 1,146,308 | -4.2% | 0.02% | -64.0% |
| Q3 2020 | $688,000 | – | 1,196,308 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Rubric Capital Management LP | 16,756,120 | $18,767,000 | 0.99% |
| Clearline Capital LP | 3,058,596 | $3,426,000 | 0.44% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 9,142,067 | $10,239,000 | 0.39% |
| DAFNA Capital Management LLC | 1,096,513 | $1,228,000 | 0.34% |
| Octagon Capital Advisors LP | 1,000,000 | $1,120,000 | 0.30% |
| Rock Springs Capital Management LP | 6,230,275 | $6,978,000 | 0.20% |
| Boxer Capital, LLC | 2,250,000 | $2,520,000 | 0.16% |
| Orbimed Advisors | 7,109,954 | $7,963,000 | 0.14% |
| Artal Group S.A. | 1,500,000 | $1,680,000 | 0.09% |
| SECTORAL ASSET MANAGEMENT INC | 385,000 | $431,000 | 0.09% |